...
首页> 外文期刊>Annals of Thoracic Medicine >Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran
【24h】

Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran

机译:与伊朗结核菌素皮肤试验相比,QuantiFERON-TB Gold试验在伊朗HIV阳性患者中检测潜伏性结核感染的性能

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: There is limited data about the performance of QuantiFERON-TB Gold (QFT-G) test in detecting latent tuberculosis infection (LTBI) in our region. We intended to determine the performance of QFT-G compared to conventional tuberculin skin test (TST) in detecting LTBI in HIV-positive individuals in Iran. Methods: This study was conducted in a HIV clinic in Tehran, Iran in April 2007. A total of 50 consecutive HIV-positive patients, not currently affected with active tuberculosis (TB), were recruited; 43 (86%) were male. The mean age was 38 ± 7.2 years (21-53). All had history of Bacillus Calmette Guerin (BCG) vaccination. A TST with purified protein derivative (PPD) and whole-blood interferon-gamma release assay (IGRA) in reaction to ESAT-6 and CFP-10 antigens was performed and measured by enzyme-linked immuno-sorbent assay (ELISA). The agreement between TST and QFT-G results were analyzed using Kappa test. Results: A total of 36 (72%) patients had negative and 14 (28%) revealed positive TST. For QFT-G, 20 (40%) tested positive, 19 (38%) tested negative, and the results in 11 cases (22%) were indeterminate. A total of 14 (28%) patients had a CD4 count of P = 0.06). Although TST results were not significantly different in patients with CD4 vs. CD4 >200 (P = 0.295), association between QFT-G results and CD4 cutoff of 200 reached statistical significance (P = 0.027). Agreement Kappa coefficient between TST and QFT-G was 0.54 (Kappa = 0.54, 95% CI = 38.4-69.6, P Conclusion: Detecting LTBI in HIV-positive individuals showed moderate agreement between QFT-G and LTBI in our study. Interestingly, our findings revealed that nontuberculous mycobacteria and prior BCG vaccination have minimal influence on TST results in HIV patients in Iran.
机译:背景:关于在我们地区检测潜伏性结核感染(LTBI)的QuantiFERON-TB Gold(QFT-G)测试性能的数据有限。我们打算确定与传统结核菌素皮肤试验(TST)相比,QFT-G在伊朗HIV阳性患者中检测LTBI的性能。方法:这项研究于2007年4月在伊朗德黑兰的一家艾滋病诊所进行。共招募了50名连续的HIV阳性患者,这些患者目前未受到活动性肺结核(TB)的影响。男性为43(86%)。平均年龄为38±7.2岁(21-53)。所有人都有卡介苗芽孢杆菌(BCG)疫苗接种史。通过酶联免疫吸附测定(ELISA)进行了与ESAT-6和CFP-10抗原反应的纯化蛋白衍生物(PPD)和全血干扰素-γ释放测定(IGRA)的TST。使用Kappa测试分析了TST和QFT-G结果之间的一致性。结果:总共36例(72%)患者的TST阴性,而14例(28%)的TST阳性。对于QFT-G,20例(40%)呈阳性,19例(38%)呈阴性,11例(22%)的结果不确定。共有14位(28%)患者的CD4计数为P = 0.06)。尽管CD4和CD4> 200的患者的TST结果无显着差异(P = 0.295),但QFT-G结果与200的CD4临界值之间的相关性具有统计学意义(P = 0.027)。 TST与QFT-G之间的一致性Kappa系数为0.54(Kappa = 0.54,95%CI = 38.4-69.6,P)结论:在我们的研究中,检测HIV阳性个体中的LTBI显示QFT-G与LTBI之间具有中等一致性。研究结果表明,非结核分枝杆菌和先前的BCG疫苗接种对伊朗HIV患者的TST结果影响最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号